Description
The main objective of the Action is improving existing therapies and finding new drugs based on dendrimers.
Action keywords
dendrimer - polymer - therapy - nanotechnology - nanomedicine
Parties
Action Leadership Positions
| Role | Leader |
|---|---|
| Action Chair | |
| Action Vice-Chair |
Management Committee
| Country | MC Member |
|---|---|
| Bulgaria | |
| Bulgaria | |
| Czech Republic | |
| Denmark | |
| Denmark | |
| Finland | |
| France | |
| France | |
| Germany | |
| Germany | |
| Greece | |
| Greece | |
| Hungary | |
| Ireland | |
| Israel | |
| Israel | |
| Italy | |
| Italy | |
| Lithuania | |
| Netherlands | |
| Norway | |
| Norway | |
| Poland | |
| Poland | |
| Portugal | |
| Romania | |
| Romania | |
| Spain | |
| Spain | |
| Sweden | |
| Sweden | |
| Switzerland | |
| Switzerland | |
| Switzerland | |
| Türkiye | |
| Türkiye | |
| Türkiye | |
| United Kingdom | |
| United Kingdom |
| Country | MC Substitute |
|---|---|
| Czech Republic | |
| Czech Republic | |
| France | |
| France | |
| Germany | |
| Germany | |
| Greece | |
| Israel | |
| Italy | |
| Italy | |
| Norway | |
| Poland | |
| Poland | |
| Romania | |
| Spain | |
| Spain | |
| Switzerland | |
| Türkiye | |
| United Kingdom |